Gas chromatography-tandem mass spectrometry analysis of gabapentin in serum

被引:28
作者
Gambelunghe, C
Mariucci, G
Tantucci, M
Ambrosini, MV
机构
[1] Univ Perugia, Dept Expt Med & Biochem Sci, Div Cellular & Mol Biol, I-06122 Perugia, Italy
[2] Univ Perugia, Dept Expt Med & Biochem Sci, I-06122 Perugia, Italy
关键词
gabapentin; GC/MS/MS analysis; serum;
D O I
10.1002/bmc.417
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new highly sensitive analytical method for determining gabapentin [1-(aminomethyl) cyclohexaneacetic acid; Neurontino((R))] in serum using gas chromatography/tandem mass spectrometry (GC-MS/MS) was developed. GC-MS/MS was applied to determine the levels of gabapentin in serum samples of mice at 1 and 6 h after oral or intraperitoneal treatment (300 mg/kg). At 1 h, the concentrations of the drug were 4.02 +/- 0.42 and 4.32 +/- 0.28 mug/mL in mice treated orally and intraperitoneally, respectively. At 6 h, drug levels decreased by about 66% in both groups. The method, coupling two stages of mass analysis, could be very useful in identifying the drug in complex mixtures such as blood and urine. Moreover, it is easy and rapid to perform, and sensitive enough to allow the presence of the drug to be determined at very low detection limits. It is a very reliable method for both clinical and experimental monitoring of gabapentin. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:63 / 67
页数:5
相关论文
共 22 条
[1]  
Finnerup Nanna B, 2002, Expert Opin Pharmacother, V3, P1411, DOI 10.1517/14656566.3.10.1411
[2]  
Gauthier D, 2002, CLIN CHEM, V48, P2259
[3]   Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability [J].
Gidal, BE ;
Radulovic, LL ;
Kruger, S ;
Rutecki, P ;
Pitterle, M ;
Brockbrader, HN .
EPILEPSY RESEARCH, 2000, 40 (2-3) :123-127
[4]   NEW ANTIEPILEPTIC DRUGS [J].
HARDEN, CL .
NEUROLOGY, 1994, 44 (05) :787-795
[5]   Rapid high-performance liquid chromatographic determination of serum gabapentin [J].
Jiang, QB ;
Li, SG .
JOURNAL OF CHROMATOGRAPHY B, 1999, 727 (1-2) :119-123
[6]  
Kushnir MM, 1999, J ANAL TOXICOL, V23, P1
[7]   Population pharmacokinetics of gabapentin in infants and children [J].
Ouellet, D ;
Bockbrader, HN ;
Wesche, DL ;
Shapiro, DY ;
Garofalo, E .
EPILEPSY RESEARCH, 2001, 47 (03) :229-241
[8]   Newer antiepileptic drugs: Possible uses in the treatment of neuropathic pain and migraine [J].
Pappagallo, M .
CLINICAL THERAPEUTICS, 2003, 25 (10) :2506-2538
[9]   A high-performance liquid chromatography micromethod for the simultaneous determination of vigabatrin and gabapentin in serum [J].
Ratnaraj, N ;
Patsalos, PN .
THERAPEUTIC DRUG MONITORING, 1998, 20 (04) :430-434
[10]   The effect of gabapentin on neuropathic pain [J].
Rosenberg, JM ;
Harrell, C ;
Ristic, H ;
Werner, RA ;
deRosayro, AM .
CLINICAL JOURNAL OF PAIN, 1997, 13 (03) :251-255